Form 4: Hologic Executive's Routine Tax-Related Stock Sale

Hologic's President of GYN Surgical, Brandon Schnittker, reported a tax-related disposition of 90 common shares at $75 per share.

Summary

• Brandon Schnittker, President, GYN Surgical at Hologic Inc. (HOLX), reported a transaction involving company common stock.
• On December 12, 2025, 90 shares of Hologic Common Stock were disposed of.
• This disposition was for tax obligations in connection with the settlement of restricted stock units (RSUs) for which service-based vesting requirements had been satisfied.
• The shares were valued at $75 each for the purpose of this tax withholding.
• Following this transaction, Mr. Schnittker beneficially owns 17,512 shares of Hologic Common Stock.

Sentiment

Score: 5

Explanation: This is a routine tax-related transaction following the vesting of restricted stock units, which is a common and expected event for executives. It does not indicate a change in company fundamentals or a discretionary sale, thus having a neutral sentiment.

Positives

• The transaction indicates the vesting of restricted stock units, implying the executive met service-based requirements for compensation.

Negatives

• A reduction of 90 shares from the executive's direct beneficial ownership.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine insider transaction for tax purposes and does not reflect a discretionary sale or significant change in the executive's investment thesis.

Key Dates

Recommendation

This Form 4 reports a routine tax-related disposition of shares following the vesting of restricted stock units. It is not a discretionary sale by the executive and therefore does not typically signal any change in the company's prospects or warrant a change in investment recommendation based solely on this filing.

Keywords

Hologic, HOLX, Form 4, insider transaction, executive compensation, restricted stock units, Brandon Schnittker, stock disposition